National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

NCT ID: NCT06356831

Last Updated: 2025-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-15

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

National multicentric registry of a cohort of patient with suffering parietal endometriosis, carried out by a multidisciplinary radiosurgery team

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patient who suffering of parietal endometriosis treat by cryoablation or chirurgical will be recorded in national registry. the patient will be follow during 3 years after treatement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis Cryotherapy Effect Surgical Radiology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound)
* Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life)

Exclusion Criteria

* Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa)
* Minor patient (\< 18 years)
* Pregnant patient at any trimester
* Patient with hemostasis disorders (constitutional or acquired)
* Patient with systemic infection or localized scar infection upon inclusion.
* Patient with contraindications to MRI
* Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.
* Patient unable to understand the information provided
* Patient who is not affiliated to the social security system
* Patient under curatorship or tutorship
* Patient with a nodule of primary or secondary malignant tumor origin
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Intercommunal Creteil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Léo RAZAKAMAMANTSOA

Role: PRINCIPAL_INVESTIGATOR

CHIC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU bordeaux

Bordeau, , France

Site Status RECRUITING

Clinique Tivoli

Bordeaux, , France

Site Status RECRUITING

CHU Clermont Ferrand

Clermont-Ferrand, , France

Site Status RECRUITING

CHI Creteil

Créteil, , France

Site Status RECRUITING

Lyon Hôpital La Croix Rousse

Lyon, , France

Site Status RECRUITING

Lyon Hôpital Sud

Lyon, , France

Site Status RECRUITING

Lyon Louis Pradel

Lyon, , France

Site Status ACTIVE_NOT_RECRUITING

APHM-Hôpital Nord

Marseille, , France

Site Status ACTIVE_NOT_RECRUITING

APHP-Hôpital la Conception La Timone

Marseille, , France

Site Status RECRUITING

CHU Montpellier

Montpellier, , France

Site Status RECRUITING

CHU Nime

Nîmes, , France

Site Status RECRUITING

AP-HP - Tenon

Paris, , France

Site Status RECRUITING

AP-HP Hôpital Européen Georges Pompidou

Paris, , France

Site Status RECRUITING

APHP Cochin-Port Royal

Paris, , France

Site Status RECRUITING

APHP-La Pitié

Paris, , France

Site Status RECRUITING

CHU Strasbourg

Strasbourg, , France

Site Status ENROLLING_BY_INVITATION

CHU Toulouse

Toulouse, , France

Site Status ACTIVE_NOT_RECRUITING

CH Valencienne

Valenciennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Léo Razakamanantsoa, Dr

Role: CONTACT

0157023567

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Clément MARCELIN, Dr

Role: primary

05 56 79 56 79

Jean-Luc BRUN, Dr

Role: backup

05 56 79 59 85

Horace ROMAN, Pr

Role: primary

05 56 52 52 53

Benoit Chauveau, Dr

Role: primary

04 73 75 07 50

Michel CANIS, Dr

Role: backup

04 73 31 60 53.

Leo RAZAKAMANANTSOA, Dr

Role: primary

0157023567

Yann SALHI, Dr

Role: backup

Audrey HAQUIN, Dr

Role: primary

04 72 07 15 07

Gil DUBERNARD

Role: backup

Alexandre GALAN, Dr

Role: primary

04 78 86 51 15

Pierre A BOLZE

Role: backup

Lisa CALDERON

Role: primary

Aubert AGOSTINI, Pr

Role: backup

0491383702

Cécile VERHEYDEN, Dr

Role: primary

0467336733

Claire VINCENS, Dr

Role: backup

Julien FRANDON, Dr

Role: primary

04 66 76 60 63

Alexis Nobileau, Dr

Role: primary

01 56 01 70 88

Yohann DABI

Role: backup

Tom BOEKEN, Dr

Role: primary

01 56 09 23 20

Henri AZAIS, Dr

Role: backup

Maxime BARAT, Dr

Role: primary

01 58 41 41 41

Anthony DOHAN, Pr

Role: backup

Charles Roux, Dr

Role: primary

0142165530

Geoffroy Canlorbe

Role: backup

Thibault POCLET, Dr

Role: primary

0327143333

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Endomecryo

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.